Alzheimer disease: open trials in Norway

9 open trials have a site in Norway. Registry data; only the trial team decides who can take part.

NCT06451952
Virtual Darkness Theraphy for Agitation in Dementia
Trial Treatment · University of Bergen
NKS Olaviken Gerontopsychiatric Hospital, Askøy
Registry updated 2026-10-21
NCT07741071
N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease
Trial Treatment · Phase 2 · Haukeland University Hospital
Haraldsplass Deaconess Hospital, Bergen · Haukeland University Hospital, Bergen
Registry updated 2026-08-20
NCT06448403
Multimodal Assesment of Alzheimer Patients
Research · Norwegian University of Science and Technology
Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU), Trondheim
Registry updated 2026-08-13
NCT07118137
Memory Deterioration in Alzheimer Disease
Research · Norwegian University of Science and Technology
Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU), Trondheim
Registry updated 2026-08-13
NCT06611878
Memory for Music: Individual Intensive Musical Training in Alzheimer's Disease
Trial Treatment · NORCE Norwegian Research Centre AS
University of Bergen, Bergen · Haraldsplass Diakonale Sykehus, Bergen · Kinn municipality, Florø · Oslo municipality, Oslo
Registry updated 2026-05-08
NCT06362707
Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
Trial Treatment · Phase 2 · Helse Stavanger HF
Haraldsplass Deaconess Hospital, Bergen · Haugesund Hospital, Haugesund · Akershus Hospital:, Oslo · Stavanger University Hospital, Stavanger · University Hospital of North Norway, Tromsø · St Olavs Hospital, Trondheim
Registry updated 2026-05-04
NCT07332260
Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study
Trial Treatment · Phase 1 · University Hospital of North Norway
University Hospital of North Norway, Tromsø, Tromsø
Registry updated 2026-04-22
NCT07105709
Open-label Extension Study in Participants With Early Alzheimer's Disease
Trial Treatment · Phase 2 · GlaxoSmithKline
Bergen · Oslo
Registry updated 2026-02-02
NCT05187819
Blood-based Biomarkers for Diagnosis of Alzheimer's
Trial Treatment · Helse Stavanger HF
Stavanger University Hospital, Stavanger
Registry updated 2023-09-28

All Alzheimer disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error